General Information of the Compound
Compound ID |
CP0404000
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3,5-Dichloro-N-{(R)-3-(3,4-dichloro-phenyl)-5-[4-(3-hydroxy-2-oxo-tetrahydro-pyrimidin-1-yl)-piperidin-1-yl]-2-[(Z)-methoxyimino]-pentyl}-N-methyl-benzamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C29H35Cl4N5O4
|
||||||||||||||||||
Molecular Weight |
659.442
|
||||||||||||||||||
Canonical SMILES |
CO\N=C(/CN(C)C(=O)c1cc(Cl)cc(Cl)c1)[C@H](CCN1CCC(CC1)N1CCCN(O)C1=O)c1ccc(Cl)c(Cl)c1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C29H35Cl4N5O4/c1-35(28(39)20-14-21(30)17-22(31)15-20)18-27(34-42-2)24(19-4-5-25(32)26(33)16-19)8-13-36-11-6-23(7-12-36)37-9-3-10-38(41)29(37)40/h4-5,14-17,23-24,41H,3,6-13,18H2,1-2H3/b34-27+/t24-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
FRVGAQVTZNXIME-VEBIXGAZSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01199, Neuromedin-K receptor
Protein ID: PT01290, Substance-K receptor
Protein ID: PT01410, Substance-P receptor